All in Cancer
By targeting drugs directly to tumours, exosome therapies can reduce side effects from cancer treatment
Exosomes are exciting treatments of the future - but how are they made?
Once thought to be little more than ‘dust’, exosomes are tiny biological mailbags that travel around the body.
Presenter Kat Arney tells the story of how biomathematician Kristin Swanson discovered that cancer cells with XX chromosomes behave differently to cancer cells with XY chromosomes.
Sam and his colleagues have discovered that the placenta is packed with genetic mutations, many of which are found in cancer.
Steve Rees and his team at AstraZeneca are focusing on the first step of the drug discovery journey: coming up with the new ideas and targets that could lead to the new medicines of tomorrow.
Andrew Steele, author of Ageless talks about the science of ageing and why your toothbrush might be more useful for preventing ageing than that fancy moisturiser.
Growing cells in the lab isn’t as easy as you might think. We explore the story of how Henrietta Lacks’s immortal cells (known today as HeLa cells) became the go-to human cell line for biomedical research, and the impact they’ve had as a result.
We tell the story of the ‘Philadelphia chromosome’ (a key cause of chronic myeloid leukaemia), how it was discovered and how it’s discovery influenced the search for a cure.
A chance encounter between a seamstress and a scientist starts a 25-year long crusade to understand the nature of hereditary cancer.
Maud Slye was one of the first people to investigate how cancer susceptibility could be inherited, with the help of 150,000 mice.
